FOLLOW-UP

A significant subset of the patients treated for urothelial carcinoma of the upper tract will subsequently develop bladder cancer. Thus it is essential to perform surveillance of all patients with regular examination, cytoscopy, urine cytology, and CT of the abdomen and pelvis for several years after initial treatment. In patients who have undergone nephron-sparing treatment, surveillance ureteroscopy is often indicated as well.